Navigation Links
Cardium Reports on Second Quarter 2008 Highlights and Financial Results

blicly the results of any revisions to these forward- looking statements to reflect events or circumstances arising after the date hereof.

Copyright 2008 Cardium Therapeutics, Inc. All rights reserved.

For Terms of Use Privacy Policy, please visit

Cardium Therapeutics(TM), Corgentin(TM) and Generx(TM) are trademarks of
Cardium Therapeutics, Inc. Tissue Repair(TM), Gene Activated Matrix(TM), GAM(TM) and Excellarate(TM) are
trademarks of the Tissue Repair Company.

InnerCool Therapies(R), InnerCool(R), Celsius Control System(TM), Accutrol(TM), CoolBlue(TM) and RapidBlue(TM)are trademarks of InnerCool

Therapies, Inc.

Cardium Therapeutics, Inc.

Three Months Ended

June 30,


Selected Condensed Consolidated 2008 2007

Operational Results

Revenues $626,841 $229,472

Cost of goods sold (314,254) (258,177)

Gross profit (loss) 312,587 (28,705)

Research and development 3,969,406 3,415,213

Selling, general and administrative 2,696,559 2,978,448

Amortization - Intangibles 197,414 207,043

Loss from operations (6,550,792) (6,629,409)

Interest income (expense), net (83,670) 228,228

Net loss $(6,634,462) $(6,401,181)

Net loss per common

share - basic and diluted $(0.15) $(0.16)'/>"/>

SOURCE Cardium Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
2. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
3. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
4. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
5. Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
6. Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
7. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
8. CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
9. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
10. Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
11. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
Post Your Comments:
(Date:9/22/2014)... Thoratec Corporation (NASDAQ: THOR ), ... to save, support and restore failing hearts, announced today ... President and Chief Executive Officer, effective immediately.  Mr. Grossman succeeds ... from his executive and Board roles but will remain ... quarter of 2016.  Mr. Grossman has ...
(Date:9/22/2014)... -- Research and Markets  has announced the addition ... 2014" report to their offering. ... a professional and in-depth study on the current state ... the Chinese situation. The report provides a ... and industry chain structure. The diclofenac market analysis is ...
(Date:9/22/2014)... , Sept. 22, 2014 China Nepstar Chain Drugstore ... leading retail drugstore chain in China based ... will hold its 2014 Annual General Meeting of Shareholders (the "AGM") ... will be held at the meeting room of the Company at ... Shenzhen , Guangdong Province 518054, ...
Breaking Medicine Technology:Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 2Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 3Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 4Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 5Global and Chinese Diclofenac Industry Report 2014 2China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 22, 2014 2
... 9 Avinger, Inc., a medical device company ... combat peripheral artery disease, announces the enrollment of ... OcclusioN CrossiNg with thE WildCat CatheTer) clinical trial. ... study intended to evaluate the Wildcat Catheter,s ability ...
... (Nasdaq: PCYC ), a biopharmaceutical company focused ... the treatment of cancer and mediated diseases, today announced ... fiscal quarter and fiscal year ended June 30, 2010 ... 2010.  The company will conduct a conference call and ...
Cached Medicine Technology:First Patient Enrolled in 'CONNECT' Clinical Trial 2Pharmacyclics Announces Date of Fiscal Year End 2010 Financial Results and Conference Call and Presentation at Stifel Nicolaus Healthcare Conference 2
(Date:9/22/2014)... of a whole eye transplant seems futuristic, if ... the U.S. Department of Defense, researchers at University ... to someday make implantation of an entire, functional ... could be a holy grail for vision restoration," ... and grant co-recipient with colleagues at University of ...
(Date:9/22/2014)... September 22, 2014 An inventor and ... to the problem of side-sleeping. "My lower arm always ... I designed a solution to this problem," she said. ... than to have your arm 'fall asleep.'" , The ... or her side more comfortably. It avoids pain and ...
(Date:9/22/2014)... September 22, 2014. Kessler researchers have published a ... psychoeducational wellness program in people with multiple sclerosis ... mental health, perceived stress, and pain. "Development ... individuals living with MS: Description and outcomes" was ... the International Journal of MS Care ...
(Date:9/22/2014)... (HealthDay News) -- Scans of young children,s brains ... This finding could potentially allow doctors to identify ... on, preliminary research suggests. "Early identification and ... as well as most neurodevelopmental disorders," the study,s ... of child and adolescent psychiatry at University of ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 Pain does not ... Pain” is a user- and reader-friendly book designed to guide ... to pain-free living. This inspirational book is written to help ... to know a way to regain a pain-free life — ... of chronic pain. , Chronic pain has become an epidemic, ...
Breaking Medicine News(10 mins):Health News:Looking ahead: Whole eye transplant under development 2Health News:Can Brain Scans Help Predict Young Children's Reading Abilities? 2Health News:Naturopathic Doctor Inspires and Guides Those Who Suffer with Chronic Pain, Pointing the Way Back to Pain-free Living 2
... Nyer Medical Group, Inc., (Nasdaq: NYER ) announced ... notifying it of its failure to maintain a minimum closing bid ... for the prior 30 consecutive business days as required by Nasdaq ... the Company has until March 15, 2010, to regain compliance with ...
... ANGELES, Sept. 21 Former House Majority leader Tom Delay, who injured ... all on the line when he and dance partner Cheryl Burke, a ... network. , , Last week, Delay was ... in Marina del Rey, Calif. headed by Dr. Robert S. Bray, Jr., ...
... , RADNOR, Pa., Sept. 21 ... today announced that its TripProtector(SM)( )insurance plans are now ... to $1 million and medical assistance services that include ... 180 countries. Most trip protection plans on the market ...
... dementia, study found , MONDAY, Sept. 21 (HealthDay News) ... people with mild memory problems will soon develop Alzheimer,s ... older people with mild cognitive impairment, and 76 others ... money management test at the start of the study ...
... Montana city, incidents fell but rose again when restrictions were ... ban smoking in bars, restaurants and other public places witness ... , The research -- which incorporated data from a total ... found at least a 17 percent reduction in heart attacks ...
... , EMERYVILLE, Calif., Sept. 21 Bionovo, Inc. (Nasdaq: ... the company received a letter from NASDAQ stating that, for the ... stock has closed below the minimum $1.00 per share requirement for ... that the company has been provided a period of 180 calendar ...
Cached Medicine News:Health News:Nyer Medical Group, Inc., Nasdaq Notification Letter 2Health News:Injured Tom Delay to Put Foot to Test in Debut of Dancing With the Stars Premiere Tonight on ABC 2Health News:HTH Worldwide Introduces Trip Protection Insurance With Major Medical Benefits 2Health News:Mishandling Money May Foreshadow Alzheimer's 2Health News:Smoking Bans Bring a Drop in Heart Attacks 2Health News:Smoking Bans Bring a Drop in Heart Attacks 3Health News:Bionovo Notified by NASDAQ of Minimum Bid Price Deficiency 2Health News:Bionovo Notified by NASDAQ of Minimum Bid Price Deficiency 3
Cloward Dowel CL18 Used for Anterior Cervical Fusion and are preserved by Freeze-dried method....
8 mm S Graftech cervical spacer....
Lorenz 2.0 mm titanium system for the midface provides an excellent alternative to lower profile systems in areas of the midface where greater fixation is needed....
... is a useful addition to ... It may be used in ... and orbital regions in all ... strength over the Leibinger Micro ...
Medicine Products: